However, to confirm its utility for early diagnosis and prognosis, systematic study in experimentally induced CMT in dogs need to be taken up for monitoring serum BIRC5 levels, before onset of tumour, during tumour progression and after surgical removal of tumour mass or chemotherapy. The gene discussed is BIRC5; the disease is neoplasm.